MENU
Home
Add Document
Sign In
Create An Account
PDF Reader
Full Text
© 1992 Nature Publishing Group
© 1992 Nature Publishing Group
© 1992 Nature Publishing Group
Suggest Documents
A human monoclonal antibody against the CD4-binding site of HIV1 gp120 exhibits potent, broadly neutralizing activity.
A broadly neutralizing monoclonal antibody that recognizes the V3 region of human immunodeficiency virus type 1 glycoprotein gp120.
Production of human monoclonal antibodies specific for conformational and linear non-V3 epitopes of gp120.
Synergistic neutralization of HIV-1 by human monoclonal antibodies against the V3 loop and the CD4-binding site of gp120.
The role of the V3 loop of gp120 in HIV infection.
Structural basis of clade-specific HIV-1 neutralization by humanized anti-V3 monoclonal antibody KD-247.
Human monoclonal antibody that recognizes the V3 region of human immunodeficiency virus gp120 and neutralizes the human T-lymphotropic virus type IIIMN strain.
macrophage infection by HIV1.
Prevention of HIV-1 IIIB infection in chimpanzees by CD4 immunoadhesin.
Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160.
Prevention of hepatitis C virus infection and spread in human liver chimeric mice by an anti-CD81 monoclonal antibody.
Product review on the monoclonal antibody palivizumab for prevention of respiratory syncytial virus infection.
Neuroprotective effects of the immunomodulatory drug FK506 in a model of HIV1-gp120 neurotoxicity.
Molecular recognition of CCR5 by an HIV-1 gp120 V3 loop.
Monoclonal antibody therapy for Junin virus infection.
Anti-idiotype monoclonal antibody elicits broadly neutralizing anti-gp120 antibodies in monkeys.
Characterization of the cDNA of a broadly reactive neutralizing human anti-gp120 monoclonal antibody.
Kinetic Analysis of Monoclonal Antibody Binding to HIV-1 gp120-derived Hyperglycosylated Cores.
Prevention of autoimmune diabetes with nonactivating anti-CD3 monoclonal antibody.
Prevention of herpes simplex virus induced stromal keratitis by a glycoprotein B-specific monoclonal antibody.
Enhanced proliferative cellular responses to HIV-1 V3 peptide and gp120 following immunization with V3:Ty virus-like particles.
Emergence of viruses resistant to neutralization by V3-specific antibodies in experimental human immunodeficiency virus type 1 IIIB infection of chimpanzees.
Identification of amino acids in the V3 region of gp120 critical for virus neutralization by human HIV-1-specific antibodies.
Infection enhancement of influenza A NWS virus in primary murine macrophages by anti-hemagglutinin monoclonal antibody.
Prevention of HIV-1 infection in chimpanzees by gp120 V3 domain-specific monoclonal antibody.
The acquired immunodeficiency syndrome (AIDS) is the late-stage clinical manifestation of long-term persistent infection with the human immunodeficien...
467KB Sizes
0 Downloads
0 Views
Download PDF
Recommend Documents
A human monoclonal antibody against the CD4-binding site of HIV1 gp120 exhibits potent, broadly neutralizing activity.
A broadly neutralizing monoclonal antibody that recognizes the V3 region of human immunodeficiency virus type 1 glycoprotein gp120.
Production of human monoclonal antibodies specific for conformational and linear non-V3 epitopes of gp120.
Synergistic neutralization of HIV-1 by human monoclonal antibodies against the V3 loop and the CD4-binding site of gp120.
The role of the V3 loop of gp120 in HIV infection.
Structural basis of clade-specific HIV-1 neutralization by humanized anti-V3 monoclonal antibody KD-247.
Human monoclonal antibody that recognizes the V3 region of human immunodeficiency virus gp120 and neutralizes the human T-lymphotropic virus type IIIMN strain.
macrophage infection by HIV1.
Prevention of HIV-1 IIIB infection in chimpanzees by CD4 immunoadhesin.
Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160.
×
Sign In
Login with Facebook
Don't have an account?
Forgot Password?
×
Sign Up
By clicking register, I agree to your terms
